FIELD: biochemistry.
SUBSTANCE: invention relates to the field of biochemistry, in particular to a genetically modified rodent, capable of demonstrating the heterotopic ossification phenotype. Said rodent comprises an Acvr1 construct inside an allele, and said construct comprises the mutant exon 5 Acvr1 in antisense orientation, flanked by a pair of site-specific recombinase recognition sites (SRRS), and additionally comprises a second pair of SRRS, directing the removal of wild-type Acvr1 exon 5 under the action of inducible site-specific recombinase, and a gene encoding the inducible site-specific recombinase. Also disclosed is a mouse embryonic stem (ES) cell of said rodent and its use as a donor cell to obtain a mouse containing the genetically modified Acvr1 allele and the tamoxifen-induced Cre-ERT or Cre-ERT2 gene. Invention also relates to a method for producing a genetically modified mouse comprising the genetically modified Acvr1 allele and tamoxifen-induced Cre-ERT or Cre-ERT2.
EFFECT: invention makes it possible to efficiently obtain a genetically modified rodent demonstrating the heterotopic ossification phenotype.
8 cl, 12 dwg, 4 tbl
Title | Year | Author | Number |
---|---|---|---|
MODEL OF PROGRESSIVE OSSIFICATION FIBRODYSPLASIYA IN RODENTS | 2019 |
|
RU2795136C2 |
NON-HUMAN ANIMALS WITH A GYRATE DEFICIENCY | 2014 |
|
RU2721855C2 |
NUCLEASE-MEDIATED TARGETING WITH LARGE TARGETING VECTORS | 2013 |
|
RU2645475C2 |
TRANSGENIC ANIMALS AND METHODS OF USE | 2011 |
|
RU2580017C2 |
TARGETED MODIFICATION OF RAT GENOME | 2014 |
|
RU2676708C2 |
ANIMALS RESISTANT TO PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS | 2012 |
|
RU2644673C2 |
METHOD FOR OBTAINING ANIMAL BEING DISTINCT AGAINST A MAN WITH A CERTAIN MUTATED GENE, METHOD FOR TESTING SUBSTANCE TO BE APPLIED FOR TREATING ALZHEIMER'S DISEASE (VARIANTS), PLASMID (VARIANTS), METHOD FOR OBTAINING PRIMARY CELL CULTURE OR SUBCULTIVATED CELL | 1999 |
|
RU2266002C2 |
SELF-INACTIVATED HELPER ADENOVIRUSES FOR PREPARING HIGH-CAPACITY RECOMBINANT ADENOVIRUSES | 2009 |
|
RU2520809C2 |
METHOD OF PRODUCING MOUSE MODEL FOR STUDYING DUCHENNE MUSCULAR DYSTROPHY AND VERSIONS OF ITS THERAPY | 2023 |
|
RU2815936C1 |
HUMANIZED MICE (HTNFKI/HTNFR2KI) ON C57BI /6 GENETIC BASIS WITH ADDITIONAL CAPABILITY OF HTNFR2 CONDITIONAL REMOVAL FOR BIOMEDICAL RESEARCH | 2019 |
|
RU2746816C2 |
Authors
Dates
2019-01-11—Published
2014-03-13—Filed